Last updated: 6 December 2021
This application seeks to permit 2′-fucosyllactose (2′-FL), produced by genetically modified
Escherichia coli K-12, in infant formula products.
Call for submissions - 6 December 2021(pdf 308 kb) (word 143 kb)
Supporting document 1 - Safety assessment (pdf 408 kb) (word 322 kb)
Administrative Assessment - 3 August 2021 (pdf 94.8 kb)(word 67.8 kb)
Executive Summary (pdf 51.2 kb)
Application (pdf 467 kb)
Applications published on our website may contain material owned by a third party. If you wish to re-use third party material, you may need to seek permission from the copyright owner.